Through immunocytochemistry staining on GBM stem cells derived from two different subtypes (mesenchymal: G411, G532, and G508 and perineural: G523 and G549), we observed significant higher CD44 expression in GBM cells derived from the mesenchymal subtype (fig. The gene discussed is CD44; the disease is glioblastoma.